Riding the tide of biopharming in Africa: Considerations for risk assessment

Simple item page
dc.contributor.authorChakauya, Ereck
dc.contributor.authorChikwamba, Rachel
dc.contributor.authorRybicki, Edward P
dc.date.accessioned2018-01-19T13:42:24Z
dc.date.available2018-01-19T13:42:24Z
dc.date.issued2006
dc.date.updated2016-01-13T07:58:02Z
dc.description.abstractIn the past few years, plant biotechnology has gone beyond traditional agricultural production of food, feed and fibre, and moved to address more complex contemporary health, social and industrial challenges. The newera involves production of novel pharmaceutical products, speciality and fine chemicals, phytoremediation and production of renewable energy resources to replace nonrenewable fossil fuels. Plants have been shown to provide a genuine and low-cost alternative production system for high-value products. Currently, the principal plant-made products include antibodies, feed additives, vaccine antigens and hormones for human and animal health, and industrial proteins. Despite the unique advantages of scalability, cost and product safety, issues of politics, environmental impact, regulation and socioeconomics still limit the adoption of biopharmaceuticals, especially in the developing world. Plant-based production systems have further complicated biosafety, gene flow and environmental impact assessments with generally genetically modified plants, topics that are already partially understood. This article provides a background to biopharming, highlighting basic considerations for risk assessment and regulation in developing countries, with an emphasis on plant-based vaccine production in South Africa.
dc.identifier.apacitationChakauya, E., Chikwamba, R., & Rybicki, E. P. (2006). Riding the tide of biopharming in Africa: Considerations for risk assessment. <i>South African Journal of Science</i>, http://hdl.handle.net/11427/26846en_ZA
dc.identifier.chicagocitationChakauya, Ereck, Rachel Chikwamba, and Edward P Rybicki "Riding the tide of biopharming in Africa: Considerations for risk assessment." <i>South African Journal of Science</i> (2006) http://hdl.handle.net/11427/26846en_ZA
dc.identifier.citationChakauya, E., Chikwamba, R., & Rybicki, E. P. (2006). Riding the tide of biopharming in Africa: considerations for risk assessment: science policy. South African journal of science, 102(7 & 8), p-284.
dc.identifier.ris TY - Journal Article AU - Chakauya, Ereck AU - Chikwamba, Rachel AU - Rybicki, Edward P AB - In the past few years, plant biotechnology has gone beyond traditional agricultural production of food, feed and fibre, and moved to address more complex contemporary health, social and industrial challenges. The newera involves production of novel pharmaceutical products, speciality and fine chemicals, phytoremediation and production of renewable energy resources to replace nonrenewable fossil fuels. Plants have been shown to provide a genuine and low-cost alternative production system for high-value products. Currently, the principal plant-made products include antibodies, feed additives, vaccine antigens and hormones for human and animal health, and industrial proteins. Despite the unique advantages of scalability, cost and product safety, issues of politics, environmental impact, regulation and socioeconomics still limit the adoption of biopharmaceuticals, especially in the developing world. Plant-based production systems have further complicated biosafety, gene flow and environmental impact assessments with generally genetically modified plants, topics that are already partially understood. This article provides a background to biopharming, highlighting basic considerations for risk assessment and regulation in developing countries, with an emphasis on plant-based vaccine production in South Africa. DA - 2006 DB - OpenUCT DP - University of Cape Town J1 - South African Journal of Science LK - https://open.uct.ac.za PB - University of Cape Town PY - 2006 T1 - Riding the tide of biopharming in Africa: Considerations for risk assessment TI - Riding the tide of biopharming in Africa: Considerations for risk assessment UR - http://hdl.handle.net/11427/26846 ER - en_ZA
dc.identifier.urihttp://hdl.handle.net/11427/26846
dc.identifier.vancouvercitationChakauya E, Chikwamba R, Rybicki EP. Riding the tide of biopharming in Africa: Considerations for risk assessment. South African Journal of Science. 2006; http://hdl.handle.net/11427/26846.en_ZA
dc.language.isoeng
dc.publisher.departmentInstitute of Infectious Disease and Molecular Medicineen_ZA
dc.publisher.facultyFaculty of Health Sciencesen_ZA
dc.publisher.institutionUniversity of Cape Town
dc.sourceSouth African Journal of Science
dc.source.urihttps://www.sajs.co.za/
dc.subject.otherRisk assessment
dc.subject.otherPlant biotechnology
dc.subject.otherAgricultural productivity
dc.subject.otherRenewable energy sources
dc.subject.otherFossil fuels
dc.subject.otherProduct safety
dc.subject.otherSocioeconomics
dc.subject.otherBiopharmaceutics
dc.titleRiding the tide of biopharming in Africa: Considerations for risk assessment
dc.typeJournal Article
uct.type.filetypeText
uct.type.filetypeImage
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Chakauya_Article_2006.pdf
Size:
280.42 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.72 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Journal Articles